Monogenec Arrhythmic Syndromes: From Molecular and Genetic Aspects to Bedside

Golukhova E Z1, Gromova O I1, Shomahov R A1

  • 1Bakoulev Centre for Cardiovascular Surgery, Rublevskoye sh. 135, 121552, Moscow, Russia.

Acta Naturae
|July 21, 2016
PubMed

Insights

Sudden cardiac death (SCD) is a fatal syndrome caused by heart rhythm disorders. This review explores the molecular and genetic basis of various SCD types and prevention strategies.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Sudden cardiac death (SCD) is the abrupt loss of cardiac function, often due to arrhythmias, causing unexpected death.
  • While coronary artery disease increases SCD risk with age, a notable incidence peak occurs below age 5 due to congenital arrhythmic canalopathies.
  • Ventricular tachyarrhythmias like VT and VF are primary causes of SCD, with bradyarrhythmias and PEA being less common immediate triggers.

Purpose of the Study:

  • To review the molecular and genetic underpinnings of various sudden cardiac death syndromes.
  • To discuss current understanding of SCD mechanisms, from ion channel physiology to monogenic disorders.
  • To outline modern prevention strategies for sudden cardiac death.

Main Methods:

  • Literature review of basic science investigations into cardiac electrophysiology and molecular genetics.
  • Analysis of molecular and genetic basis for specific SCD conditions.
  • Overview of contemporary SCD prevention techniques.

Main Results:

  • Identified congenital monogenic arrhythmic canalopathies as a cause for SCD in young children.
  • Detailed the role of ventricular tachyarrhythmias as the primary mechanism of SCD.
  • Highlighted the contribution of ion channel dysfunction and genetic mutations to inherited arrhythmia syndromes.

Conclusions:

  • Understanding the molecular and genetic basis of SCD is crucial for developing effective prevention strategies.
  • Specific syndromes like Long QT syndrome, Brugada syndrome, and others share common molecular pathways.
  • Modern interventions, including implantable cardioverter-defibrillators, offer improved prevention for at-risk individuals.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.5K
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
451
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
814
Dysrhythmias I: Introduction01:15

Dysrhythmias I: Introduction

Dysrhythmias refers to abnormalities in the heart's rhythm. They result from disruptions in the heart's electrical conduction system, which includes the sinoatrial(SA)node, atrioventricular(AV) node, the bundle of His, bundle branches, and Purkinje fibers.Definition and PathophysiologyDysrhythmias result from disorders of impulse formation, impulse conduction, or both. The heart contains specialized cells in the sinoatrial node, atrioventricular node, and the bundle of His and Purkinje fibers...
750
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
591
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
753